← Back to Clinical Trials
Recruiting NCT06271915

NCT06271915 Role of Cervical Spine Mobilization on Lateral Epicondylitis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06271915
Status Recruiting
Phase
Sponsor Cairo University
Condition Lateral Epicondylitis
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-02-15
Primary Completion 2024-09-15

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
SNAGs - eccentric exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-02-15 with a primary completion date of 2024-09-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study's primary goal is to examine the effectiveness of Mulligan's technique in reducing hyperalgesia in lateral epicondylitis, focusing on cervical spine, while also investigating its influence on central sensitization in relation to lateral epicondylitis.

Eligibility Criteria

Inclusion Criteria: * a positive Maudsley's test and Cozen's test, * positive Spurling and axial distraction tests * limited range of motion of the cervical spine * a positive upper limb tension test (ULTT) * middle-aged individuals (40-60 years old). Exclusion Criteria: * participants with any pathologies * participants involved in other studies * patients undergoing corticosteroids treatment * physical therapy sessions, or surgical interventions for elbow or cervical spine issues within the past year * individuals afflicted by inflammatory, infectious, or systematic diseases * participants experiencing bilateral elbow pain or tumor diseases are excluded.

Contact & Investigator

Central Contact

Ahmad El Melhat, Phd

✉ ahmed.elmelhat@cu.edu.lb

📞 01112595022

Frequently Asked Questions

Who can join the NCT06271915 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, up to 50 Years, studying Lateral Epicondylitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06271915 currently recruiting?

Yes, NCT06271915 is actively recruiting participants. Contact the research team at ahmed.elmelhat@cu.edu.lb for enrollment information.

Where is the NCT06271915 trial being conducted?

This trial is being conducted at Giza, Egypt.

Who is sponsoring the NCT06271915 clinical trial?

NCT06271915 is sponsored by Cairo University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology